Therapeutic Group

Indication Dosage

Letrozole is a medication primarily prescribed to postmenopausal women with hormone receptor-positive breast cancer. It is used as an adjuvant treatment following surgery or radiation to lower the risk of cancer recurrence. Letrozole works by reducing the production of estrogen in the body, which can help slow down or inhibit the growth of cancer cells that rely on estrogen for their development.

First-line Treatment In Postmenopausal Women With Hormone-dependent Advanced Breast Cancer, Adjuvant Treatment Of Oestrogen-receptor-positive Invasive Early Breast Cancer In Postmenopausal Women, Extended Adjuvant Treatment Of Hormone-dependent Invasive Breast Cancer In Postmenopausal Women Who Have Received Standard Adjuvant Tamoxifen Therapy For 5 Years, Neo-adjuvant Treatment In Postmenopausal Women With Localized Hormone-receptor-positive, Human Epidermal Growth Factor-2 Negative Breast Cancer Where Chemotherapy Is Not Suitable And Surgery Not Yet Indicated: 

• Adult: 2.5 Mg Daily

Content

Pregnancy

Positive Evidence Of Risk: Avoid

Stability

Contra Indications

Precautions

Lactation

Side Effects